Novagant Inc. to update its shareholders and supporters that it is aggressively in the process of expanding its Cannabidiol (CBD) product line as a follow-up to its recent announcements of its GLAVAPE(TM) (Generally Legal American Vape) medical cannabis vaporizer product based on CBD-rich hemp oil and of its newly launched E-Commerce portal website for its new GLAVAPE(TM) product. The company has been developing its legal hemp product line and marketing strategies for its points of entry for retail sales to take advantage of a potential $8.4 billion medical cannabis industry.